Monoclonal Anti‐K14 and Anti‐K2
Authors:
- 1 April 1987
- journal article
- research article
- Published by Wiley in Vox Sanguinis
- Vol. 52 (3) , 231-235
Abstract
Mouse hybridoma clones have produced monoclonal antibodies directed against the K:14 and K:2 high‐incidence antigens of the Kell blood group system. Two examples of anti‐K14 were isolated, each arising from a separate fusion procedure. All three monoclonal antibodies are of the immunoglobulin class IgGl. Serological activity is consistent with that seen with human antibodies to high‐incidence Kell system antigens, and their epitopes are destroyed, as usual, by 2‐aminoethylisothiuronium bromide treatment. Specificity was further confirmed by adsorption and elution studies. Tests against nonhuman primate red cells demonstrated the expression of K:14 only by the great apes, whereas K:2 was present on all red cells tested. These findings emphasize the usefulness of monoclonal antibodies to elucidate the evolutionary patterns of blood group variants.Keywords
This publication has 21 references indexed in Scilit:
- BRIC 18: A MONOCLONAL ANTIBODY WITH A SPECIFICITY RELATED TO THE KELL BLOOD GROUP SYSTEMInternational Journal of Immunogenetics, 1982
- Letter to the EditorVox Sanguinis, 1982
- The Côté Serum (Anti‐K11), an Antibody Defining a New Variant in the Kell SystemVox Sanguinis, 1976
- Anti‐K14: an Antibody Specificity Associated with the Kell Blood Group System1Vox Sanguinis, 1976
- Wka(Weeks), a New Antigen in the Kell Blood Group SystemVox Sanguinis, 1974
- Anti‐K13 and the K:‐13 PhenotypeVox Sanguinis, 1974
- Three Further Antigen‐Antibody Specificities Associated with the Kell Blood Group SystemVox Sanguinis, 1973
- Js, a ‘New’ Blood Group Antigen found in NegroesNature, 1958
- A ‘New’ Kell Blood-Group PhenotypeNature, 1957
- IN-VIVO ISOSENSITISATION OF RED CELLS IN BABIES WITH HÆMOLYTIC DISEASEThe Lancet, 1946